BBIO Bears Retreat After Earnings as Analysts Raise Targets
BridgeBio Pharma has flipped its positioning story in 48 hours — shorts are covering at pace, analysts are lifting targets in unison, and the options tape has swung from extreme bullishness to a defensive pulse that…
